Building on the experience of the EU Task Force for Industrial Scale-up of COVID-19 vaccines and therapeutics, the European Commission remains promoting cooperation among actors in the EU supply chain to ensure that available therapeutics are produced in sufficient quantity as soon as possible. For this reason, the Second Virtual Matchmaking Event on COVID-19 Therapeutics is in preparation!
On the 29 and 30 November, the European Commission is organising the Second Virtual Matchmaking Event on COVID-19 Therapeutics together with the Council of European BioRegions (CEBR), the European Cluster Alliance (ECA) and the ECCP.
DAY 1 - Monday, 29th November, 2021
9:00h - 12:00h (CET) - Launch of the EU matchmaking event on COVID19 Therapeutics: Experts seminar
13:00h - 17:00h (CET) - Matchmaking meetings
DAY 2 - Tuesday, 30th November, 2021
09:00 - 17:00h (CET) - Matchmaking meetings
The aim of this event is to accelerate:
1. The development of new and repurposed medicines for COVID-19 therapeutics
2. The development of medicines used to treat the symptoms of COVID-19
3. The production of disposable materials (e.g. single use systems), ingredients and raw materials required for the manufacture of medicinal products
Furthermore, it will also aim to mobilise the EU pharma manufacturing capacity for the production of medicines to treat and prevent COVID-19.
Who can join?
The entire EU COVID-19 therapeutics supply chain that have development or production facilities in the EU, such as clinical research organisations, treatment developers, funding providers and manufacturing suppliers is welcome to join the event.
In their applications, companies must be specific on the technology they use and on how their capacities are relevant for the purpose of this event. Besides, companies will only be formally registered if the criteria detailed in the event’s Call for Expression of Interest is met.
Companies interested in participating in the event must complete the event’s registration form by 18 November 2021 (23h59 CEST). You can register here.
Any questions can be addressed to Daniela Coutinho and Raquel Gonçalves, from the European Cluster Collaboration Platform at email@example.com